Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 29.45B | 27.58B | 24.62B | 31.32B | 28.58B |
Gross Profit | 2.55B | 2.43B | 2.23B | 3.27B | 3.36B |
EBITDA | 1.17B | 1.14B | 921.00M | 2.00B | 2.10B |
Net Income | 921.00M | 685.00M | 523.00M | 1.25B | 1.32B |
Balance Sheet | |||||
Total Assets | 25.30B | 27.39B | 23.78B | 25.41B | 23.60B |
Cash, Cash Equivalents and Short-Term Investments | 4.48B | 9.57B | 9.43B | 9.18B | 7.73B |
Total Debt | 831.00M | 827.00M | 831.00M | 821.00M | 929.00M |
Total Liabilities | 10.40B | 13.03B | 9.72B | 11.45B | 10.45B |
Stockholders Equity | 14.90B | 14.36B | 14.06B | 13.97B | 13.14B |
Cash Flow | |||||
Free Cash Flow | -4.45B | 617.00M | 711.00M | 2.02B | -325.00M |
Operating Cash Flow | -4.23B | 680.00M | 799.00M | 2.10B | -228.00M |
Investing Cash Flow | -407.00M | -70.00M | -80.00M | -78.00M | -74.00M |
Financing Cash Flow | -466.00M | -468.00M | -468.00M | -569.00M | -474.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥10.94B | 5.06 | 2.01% | 24.64% | 35.00% | ||
80 Outperform | ¥14.04B | 7.54 | 1.21% | 23.15% | 46.68% | ||
77 Outperform | ¥11.57B | 5.80 | 4.44% | 7.07% | -0.67% | ||
75 Outperform | ¥10.58B | 10.27 | 4.49% | 3.49% | 9.50% | ||
72 Outperform | ¥10.51B | 10.01 | 4.36% | -4.01% | 42.07% | ||
64 Neutral | $10.95B | 16.37 | 8.81% | 1.96% | 2.68% | -15.33% | |
63 Neutral | ¥9.58B | 3.82 | 2.39% | 12.27% | 682.78% |